RBCUX | TEBCX | RBCUX / TEBCX | |
Total Expense Ratio | 0.41 | 1.30 | 32% |
Annual Report Gross Expense Ratio | 0.57 | 1.30 | 44% |
Fund Existence | 9 years | 25 years | - |
Gain YTD | 3.761 | 0.969 | 388% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.17B | 23.8B | 26% |
Annual Yield % from dividends | 3.70 | 2.28 | 163% |
Returns for 1 year | 3.04 | -0.10 | -2,943% |
Returns for 3 years | 14.33 | 6.65 | 216% |
Returns for 5 years | 2.69 | -5.97 | -45% |
Returns for 10 years | N/A | -1.61 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PJP | 94.07 | 0.64 | +0.68% |
Invesco Pharmaceuticals ETF | |||
SAGP | 34.02 | 0.07 | +0.21% |
Strategas Global Policy Opp ETF | |||
OOSP | 10.18 | 0.01 | +0.05% |
Obra Opportunistic Structured Prdcts ETF | |||
GEM | 41.42 | -0.04 | -0.10% |
Goldman Sachs ActiveBeta® EMkts Eq ETF | |||
RBLU | 88.56 | -2.76 | -3.02% |
T-Rex 2X Long RBLX Daily Target ETF |